Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1894316Generated: November 1, 2026

1-(3-(Methylsulfonyl)propyl)piperazine → HCID 25261975, compound

https://huagongshe.com/reaction/1894316

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(3-(Methylsulfonyl)propyl)piperazineHCID 49853478—
Reactantrac-(4S*,5R*)-2-(2-tert-butyl-4-ethoxy-pyrimidin-5-yl)-4,5-bis-(4-chloro-phenyl)-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chlorideHCID 76588520—
ProductHCID 25261975HCID 25261975—

Reaction Steps

In a manner analogous to the method described in example 3, rac-(4S*,5R*)-2-(2-tert-butyl-4-ethoxy-pyrimidin-5-yl)-4,5-bis-(4-chloro-phenyl)-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chloride was reacted with 4-[3-(methylsulfonyl)propyl]-piperazine (prepared as described in Fotouhi, N. et al. WO 2005110996) to give the title compound as a racemic mixture. The enantiomers were then separated by supercritical fluid chromatography (Berger Instrument Multi-Gram II, Daicel ChiralPak OD-H 3'25 cm, 35° C. at 100 bar, eluting with 35% methanol in carbon dioxide). HR-MS (ES, m/z) calculated for C36H47Cl2N6O4S [(M+H)+] 729.2751, observed 729.2749.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08513239B2
Source datasetuspto-grants-2013_08
ORD IDord-648d8d6296534de7aa08fbff913f1614
Source noteuspto-grants-2013_08